Decision-grade measurement

Decision-grade metrics

• Priority use cases with named decision, workflow owner, baseline, target, and value hypothesis
• Active users, eligible use, action rate, completion, abandonment, and time from insight to intervention
• Clinical, operational, financial, access, experience, and equity outcomes linked to each use case
• Completeness, validity, timeliness, consistency, uniqueness, provenance, and reconciliation by critical field
• Enterprise measures using approved definitions, with exceptions and conflicting versions retired
• Interface success, latency, matching, mapping defects, rejected messages, and reconciliation workload
• Model discrimination and calibration where relevant, plus false-positive and false-negative consequences
• Performance and outcome by relevant population, location, language, payer, age, sex, race, ethnicity, disability, or other justified dimensions
• Overrides, alert burden, drift, safety signals, complaints, review triggers, and corrective actions
• Privacy and security incidents, inappropriate-access findings, vendor exceptions, and access-review completion
• Total lifecycle cost, capacity released, cash effect, adoption, and benefit sustained over time
• Data products meeting ownership, lineage, quality, retention, access, and service-level expectations

Publish denominators, time periods, definitions, limitations, and confidence where appropriate. Avoid a single composite score that can conceal poor performance for a critical subgroup or workflow.

Operating-model guardrails

Keep data ownership with the business and clinical leaders who understand meaning and consequences, while technical teams manage reliable platforms and pipelines. A central team should set shared architecture, governance, and methods; domain teams should remain accountable for definitions, workflow, adoption, and outcomes. Establish one route for intake and prioritization so urgent requests do not permanently displace strategic work.

Require documentation that survives employee and vendor turnover. Maintain source code or configuration access where contractually available, model and dashboard versions, decision logs, validation evidence, data-use approvals, and recovery procedures. Budget for monitoring and retirement as well as launch. An unused dashboard, unsupported interface, or unmonitored model is a liability, not an asset.

Executive questions

Frequently asked questions

Should an organization build a data lake first?

Not necessarily. Begin with priority decisions and the minimum trusted data needed to support them. A platform may be part of the solution, but architecture without use, stewardship, and workflow ownership can increase cost and risk.

Who owns data quality?

Ownership is shared but must be explicit. Domain leaders own meaning and fitness for use, frontline processes influence capture, stewards coordinate correction, and technical teams manage pipelines and controls. One named owner should resolve each critical issue.

Does analytics need to be real time?

Only when the decision requires it. Define the maximum useful latency for the workflow, then engineer and monitor to that requirement.

Is de-identified information outside every privacy concern?

No. HIPAA de-identification can change obligations under the Privacy Rule, but re-identification, linkage, contracts, state law, ethics, security, and community expectations may still matter. Review the specific use and data environment.

How should leaders evaluate an AI vendor?

Ask for intended use, training and validation data, subgroup performance, workflow evidence, limitations, update process, monitoring, security, data rights, incident response, regulatory status, and exit support. Validate consequential tools in the local context and retain accountable human oversight.